MeCure Industries Plans N50bn Capital Raise Amid Profit Surge

MeCure Industries Plc has proposed a capital raise of N50 billion, increasing its capital raising program from N30 billion, following a remarkable financial performance in 2025. The company's revenue rose by 69% to N77.69 billion from N46.03 billion in 2024, with profit before tax nearly doubling to N16.43 billion from N8.28 billion, reflecting a 177% increase to N6.46 billion.

This performance was discussed during the company's third Annual General Meeting (AGM) held in Lagos, where shareholders approved a dividend of 32 kobo per ordinary share, amounting to N1.29 billion. Chairman Samir Udani emphasized the company's commitment to strong corporate governance and operational efficiency despite challenges in the macroeconomic environment.

MeCure also secured regulatory approval for 19 new pharmaceutical products and plans to enter the Sierra Leone market as part of its West African growth strategy.